IMATINIB MESYLATE 100 MG TAB

Imatinib Mesylate
$0.7940per EA
High Outlier

Strength

100 mg/1

NDC

68001062205

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

IMATINIB MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA212773

On Market Since

12/6/2024

Pharmacological Classes

Bcr-Abl Tyrosine Kinase Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor

Price History

1W

0.0%

1M

-4.0%

3M

-7.7%

6M

-10.7%

1Y

-3.5%

3Y

N/A

5Y

N/A

All

+9.2%